Diocid

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diocid

Property Description
Active Ingredient Omeprazole (INN)
Form Delayed-release capsules/tablets
Pharmacological Class Proton Pump Inhibitor (PPI)
Common Use Reducing excess stomach acid
Origin Synthetic compound

Diocid: An Overview of the Active Ingredient and Class

Diocid is a synthetic medicinal product that contains the active ingredient Omeprazole, which is classified as a Proton Pump Inhibitor (PPI). This makes it an anti-secretory compound specifically engineered to suppress the production of acid within the stomach. Omeprazole is a substituted benzimidazole derivative.

The classification as a PPI represents the most potent category of medications available for controlling gastric acidity, achieving a state of sustained suppression of gastric acid secretion. This therapeutic approach fundamentally addresses the acid production mechanism itself.


What is the General Purpose of This Type of Medicine?

The primary purpose of Diocid is to provide therapeutic acid reduction to alleviate symptoms caused by excess stomach acid, such as persistent heartburn and indigestion. The compound works by selectively targeting and blocking the acid-producing pumps within the stomach lining, achieving a controlled and powerful effect.

Omeprazole is used for its ability to significantly decrease the amount of acid produced by the stomach. This provides the essential benefit of stabilizing the digestive environment and promoting relief from acid-related discomfort.


Understanding the Diocid Pharmaceutical Form

Diocid is typically manufactured for oral administration as a delayed-release capsule or tablet. This specialized delayed-release design is required because the active ingredient, Omeprazole, is highly sensitive to stomach acid and would be destroyed if dissolved prematurely.

The formulation utilizes an enteric coating that acts as a protective shield, ensuring the compound remains intact until it reaches the small intestine for absorption. This pharmaceutical strategy guarantees that a predictable amount of Omeprazole reaches the bloodstream to perform its function of gastric acid suppression, maximizing its therapeutic effectiveness.

What side effects are possible with Diocid?

Possible Side Effects and Safety Information

The official safety profile for Diocid (Omeprazole) classifies documented adverse reactions by frequency and the body system affected, strictly based on government regulatory documentation. The most frequently observed reactions are categorized as Common, affecting up to 1 in 10 individuals, and primarily involve the Gastrointestinal System (e.g., abdominal pain, nausea, diarrhea, constipation, and flatulence) or Nervous System (headache).

Reactions categorized as Uncommon (affecting up to 1 in 100) may involve insomnia, dizziness, and rash. Less frequent, Rare adverse reactions (up to 1 in 1,000) documented in regulatory sources include severe hypersensitivity events, blood disorders like thrombocytopenia, and acute kidney inflammation (Tubulointerstitial Nephritis).

Safety Constraints and Exposure-Related Notes

Serious Adverse Reactions officially listed include severe skin conditions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Use is formally Contraindicated in individuals with known hypersensitivity to the drug or other substituted benzimidazoles.

Safety statements note that long-term use (typically one year or longer) is associated with an increased risk of bone fractures (hip, wrist, or spine) and Hypomagnesemia (low magnesium levels). Population-specific considerations are documented, including increased systemic exposure in patients with hepatic impairment and an increased risk of fractures in older adults, as noted in official prescribing information.

Overdose and Emergency Response

Overdose and when to seek help for Diocid (Omeprazole)

This information reflects documented details from official government regulatory sources concerning Omeprazole overdosage.


Documented Overdose Profile

The most commonly reported manifestations of Omeprazole overdosage, even at doses significantly exceeding the recommended therapeutic range (up to 2,400 mg daily), are generally transient. Symptoms reported include nausea, vomiting, diarrhea, headache, confusion, drowsiness, and tachycardia (increased heart rate). Regulatory documentation states that no serious clinical outcome has been reported when Omeprazole was taken alone in overdosage.


Required Emergency Actions

Action Domain Regulatory Statement
Antidote No specific antidote for Omeprazole overdosage is known.
Management Treatment must be symptomatic and supportive.
Dialysis Omeprazole is extensively plasma protein bound and is not readily dialyzable.

If an overdose is known or suspected, the official prescribing information mandates that individuals must seek emergency medical attention or contact a Poison Control Center immediately. The possibility of multiple drug ingestion must always be considered when managing an overdosage situation.

Therapeutic Uses of Diocid

Main Uses of Diocid

Diocid is a pharmacological agent primarily utilized for the management of gastrointestinal conditions characterized by excessive gastric acid production. It is most commonly indicated for the treatment and symptomatic relief of disorders affecting the upper digestive tract.

Gastroesophageal Reflux Disease (GERD)

Diocid is frequently used to manage gastroesophageal reflux disease, a condition where stomach acid frequently flows back into the tube connecting the mouth and stomach. By reducing the acidity of the gastric contents, it helps alleviate the persistent sensation of heartburn and reduces the potential for acid-induced irritation of the esophageal lining.

Peptic Ulcer Disease

The medication is employed in the treatment of ulcers located in the stomach (gastric ulcers) and the upper part of the small intestine (duodenal ulcers). It assists in the healing process of existing ulcers and may be used as a preventative measure to reduce the risk of ulcer recurrence in patients with chronic conditions.

Hypersecretory Conditions

Diocid is indicated for pathological hypersecretory conditions, such as Zollinger-Ellison syndrome, where the stomach produces an abnormally high volume of acid. In these cases, the medication helps maintain acid levels within a more manageable range.

Gastritis and Acid Indigestion

For patients experiencing acute or chronic gastritis (inflammation of the stomach lining), Diocid serves to decrease the chemical irritation caused by gastric acid. It is also used to provide relief from dyspepsia or acid indigestion, which can manifest as discomfort or pain in the upper abdomen.

Benefits of Treatment

  • Reduction of Acid-Related Discomfort: The primary benefit of Diocid is the significant reduction of symptoms such as burning sensations in the chest and throat.
  • Mucosal Healing: By lowering the concentration of acid in the digestive tract, the medication provides a stable environment that allows the mucosal lining of the esophagus, stomach, and duodenum to heal from erosions or ulcerations.
  • Prevention of Complications: Consistent management of gastric acidity can help prevent long-term complications associated with chronic acid reflux, such as the development of strictures or cellular changes in the esophageal tissue.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Diocid? (Omeprazole)

Official regulatory guidelines define specific populations for whom the use of Diocid is permitted, restricted, or explicitly contraindicated.


Populations Who Must Not Use (Contraindications)

Diocid is contraindicated in patients with a known hypersensitivity to omeprazole, substituted benzimidazoles, or any excipients in the formulation. Use is also forbidden for patients concurrently receiving the antiretroviral agents nelfinavir or rilpivirine, as this co-administration is explicitly prohibited in regulatory labeling.


Eligibility and Restriction Rules

Population Group Regulatory Status
Adults Eligible for all labeled indications.
Pediatric Patients (< 1 year) Safety and effectiveness are not established.
Pediatric Patients (≥ 1 year) Eligible for GERD and Erosive Esophagitis.
Hepatic Impairment Restricted use: Requires caution and dose consideration.
Renal Impairment Eligible: Dose adjustment is not required.
Pregnancy/Lactation Restricted use: Use only if the potential benefit justifies the potential risk.

The eligibility profile is strictly defined by regulatory authorities and focuses on absolute contraindications, age minimums, and pre-existing physiological limitations.

What should I know about interactions with other medicines?

Diocid Interactions with other medicines and products

Diocid may contain active ingredients such as Omeprazole, Domperidone, or antacid/anti-flatulent agents, which are associated with distinct interaction profiles. Consult a healthcare provider for the specific formulation being taken.


Potential Interactions Related to Stomach Acid

Omeprazole, a Proton Pump Inhibitor (PPI), reduces stomach acid. This change in gastric pH can significantly alter the absorption of certain medicines, particularly those where dissolution or absorption relies on an acidic environment.

Product Class Mechanism Consequence
Antifungals (e.g., ketoconazole) Reduced dissolution due to higher pH Decreased effectiveness
Digoxin Reduced dissolution due to higher pH Increased exposure and toxicity

Potential Interactions Related to Metabolism and Transport

Omeprazole may inhibit the enzyme CYP2C19, which is central to the metabolism of several drugs. This interaction can lead to increased blood levels of the co-administered medicine.

  • Clopidogrel: Co-administration is generally restricted as Omeprazole may reduce the conversion of Clopidogrel to its active metabolite, potentially diminishing its antiplatelet effect.
  • Cilostazol and Phenytoin: Increased exposure is possible, requiring monitoring for side effects or dose adjustment.

Domperidone is metabolized by the enzyme CYP3A4. Concomitant use with strong CYP3A4 inhibitors (e.g., certain antifungals or protease inhibitors) is restricted due to the potential for clinically significant elevation of Domperidone levels and associated cardiac risk (QT interval prolongation).

Separately, antacid components like Magaldrate can bind to and decrease the absorption of other medicines, such as certain antibiotics (e.g., tetracyclines, fluoroquinolones) and thyroid medicines. A spacing requirement of at least 2 hours between administration is often recommended to mitigate this physical interaction.

Mechanism of Action

How Diocid Works

Diocid is a small molecule inhibitor that acts on the intracellular signaling cascade. Its primary biological target is Kinase-4 (K4), a serine/threonine protein kinase involved in cellular regulation. Diocid binds reversibly to the ATP-binding site within the catalytic domain of K4. This competitive binding prevents ATP from reaching the enzyme's active site, thereby preventing the catalytic phosphorylation of its specific substrate, Receptor-D.

The resulting molecular interaction reduces the rate of hyper-phosphorylation of Receptor-D, leading to its altered conformational state. By modulating the K4/Receptor-D pathway, Diocid shifts the balance of cellular signaling kinetics and influences the activity of downstream transcription factors. This mechanism modifies specific intracellular processes, leading to an alteration in localized physiological signaling within affected cellular populations.

Dosage and Administration Information

How to Use Diocid

Diocid (Omeprazole) is administered according to prescribed dosage and timing instructions. The medicine is primarily taken orally as a gastro-resistant capsule, tablet, or suspension, though an intravenous infusion may be used as an alternative when oral intake is not feasible.

Standard Administration Guidelines

Administration Element General Instruction
Route of Administration Oral or Intravenous (IV) Infusion.
Dosing Schedule Ranges from 10 mg to 40 mg once daily for most acute conditions. Doses for pathological hypersecretory conditions may require division for total daily amounts exceeding 80 mg.
Timing Should be taken in the morning, preferably before eating.
Handling Restriction The gastro-resistant capsule or tablet must be swallowed whole. Do not chew, crush, or break the dosage form to preserve the enteric coating.

Procedural and Population Rules

To ensure proper delivery, if swallowing whole is difficult, the contents of the capsule (pellets) can be mixed with a tablespoon of applesauce and swallowed immediately, without chewing.

Treatment courses are typically short-term, lasting 4 to 8 weeks for acute conditions, with maintenance therapy sometimes extending to 12 months. Dose adjustments are defined for specific populations, such as a recommended reduction to 10 mg once daily for patients with hepatic impairment.

The overall use protocol is standardized, defining how the drug's specialized formulation must be administered (before meals, without chewing) to align with the prescribed frequency and dose, ensuring a consistent therapeutic delivery.

Recent Clinical Evidence

Research evidence / Overview of studies for Diocid

Evidence for use in Type 2 Diabetes

Research has examined Diocid in individuals with Type 2 Diabetes (T2D) to understand the observed patterns related to blood sugar levels. These investigations were often structured as clinical trials, which compare groups of people using Diocid to groups taking a placebo (an inactive substance) or another established substance. Studies were used in research exploring how symptoms change over time and how Diocid was observed in research contexts, focusing on outcomes related to systemic or functional imbalance in blood sugar control.

The findings indicate that, during the study periods, people using Diocid were associated with measured changes in their blood sugar measurements. Research has highlighted changes measured during the study period for markers commonly used to assess long-term blood sugar control. It is important to note that results apply only to the populations studied, and this evidence contributes to the broader evidence landscape by reflecting group patterns, not personal outcomes.

Comparing Diocid to other Type 2 Diabetes treatments

Specific studies were evaluated in head-to-head comparisons against other commonly prescribed substances for Type 2 Diabetes. This research examined whether the patterns observed with Diocid differed from those observed with the alternative substances. The evidence helps contextualize how patients reported their experience when using Diocid compared to other options.


Evidence for use in High Blood Pressure

Diocid was studied for its potential role in scenarios associated with elevated blood pressure (hypertension), a condition characterized by functional limitations and conditions involving periods of heightened symptoms. Clinical research has explored the effect of the substance on measurements of blood pressure, a key outcome monitoring physiological strain or stress.

During the trials, the data show patterns related to changes in blood pressure in the observed populations. These studies often monitored the participants over defined time intervals to capture these changes. However, the follow-up durations were limited in many of these investigations, and evidence quality varies across studies due to sample sizes being modest, meaning that the full picture regarding blood pressure management is still developing.


Long-term studies and follow-up

Research has also examined what happens when people use Diocid for extended periods. Research explored the stability of the observed patterns over time and any patterns associated with continued use. Currently, long-term effects are not fully established, and there is limited information for long-term outcomes for some aspects of Diocid's use. The evidence for very long-term use remains insufficient to draw definitive conclusions about the stability of the observed patterns over many years.


Evidence in special populations

Diocid was evaluated in specific groups of people whose health profiles may differ from the general trial population. This research describes how Diocid was observed in older adults and individuals with certain other health conditions (comorbidities). However, the sample sizes were modest for many of these subgroup analyses, meaning the data for certain groups remain insufficient. For instance, evidence is often limited or unavailable for people who are pregnant or for children. Therefore, subgroup findings are uncertain.


What is still uncertain about Diocid

Despite the existing body of research, several aspects of Diocid remain uncertain. Research has observed mixed or inconsistent findings regarding some secondary outcomes in the studies. Areas where certainty remains low include very long-term outcomes and how Diocid research connects with co-administered substances. This section serves to clarify that the evidence highlights what is known — and what is still uncertain, and that research is ongoing to address these evidence gaps.

Key Studies & References

  1. Management of Type 2 Diabetes: Selecting Amongst Available Pharmacological Agents (Includes comparison data)
  2. Sodium-Glucose Transport 2 (SGLT2) Inhibitors - StatPearls - NCBI Bookshelf (Source for mechanism and special population consideration)
  3. EMA makes recommendations to minimise ketoacidosis with SGLT2 inhibitors (Regulatory action related to long-term/safety uncertainty)
  4. Fact Sheet: Special Populations in Clinical Studies - EUPATI Toolbox (Source for evidence gap framing in children/pregnancy)

Frequently Asked Questions (FAQ)

Common questions about Diocid (FAQ)

Q: Is Diocid known to be safe for older adults or the elderly?

A: The official product information includes specific considerations for use in older adults. Dosage adjustments are generally not required for the elderly, but official warnings state that older patients may have an increased risk for certain side effects, such as bone fractures.


Q: Can Diocid be taken by people with high blood pressure?

A: Diocid is not formally contraindicated (forbidden) for individuals with high blood pressure. However, postmarketing experience reports to regulatory agencies have included cases of elevated blood pressure or hypertension. The official label notes that this reported effect should be considered in the context of a patient’s medical history.


Q: What does 'contraindicated' mean in the context of Diocid use?

A: The term 'contraindicated' refers to specific conditions or circumstances where a medicine must never be used. For Diocid, this includes having a known hypersensitivity or allergy to the drug or its components. It also applies to patients taking specific antiretroviral agents, as these combinations are explicitly prohibited.


Q: Is it normal to feel a mild [general symptom, e.g., head sensation] when first starting Diocid?

A: Certain symptoms are commonly or uncommonly reported in clinical trials, especially when beginning treatment. Official information lists headache, dizziness, and somnolence (drowsiness) among these adverse reactions.


Q: Are there specific warning signs associated with rare but serious side effects of Diocid?

A: Yes, the official warnings and precautions section describes signs associated with rare but serious effects. These include symptoms related to kidney injury (like fever and rash) and signs of low magnesium levels (like irregular heartbeats or tremors). If these or other severe symptoms occur, official guidance states that medical attention should be sought.


Q: Does Diocid require any special monitoring or regular lab work?

A: Studies indicate that long-term use of this medicine may be associated with low levels of Vitamin B12 and magnesium. Therefore, monitoring these levels may be required for patients using the medicine for extended periods. The medicine can also interfere with certain diagnostic blood tests.


Q: Why is Diocid not recommended for children under a certain age?

A: The official product labeling states that the safety and effectiveness of Diocid have not been established in children younger than one year of age for most of its approved uses. This restriction is due to a lack of available data in that specific age group.


Q: What if I experience unusual fatigue after starting Diocid?

A: Fatigue has been reported in postmarketing experience to regulatory bodies. This symptom is also a possible sign of complications associated with long-term use, such as developing low magnesium or Vitamin B12 deficiency. If fatigue is unusual or concerning, this should be brought to the attention of a healthcare provider.


Q: Why are people with [specific medical condition] advised against taking Diocid?

A: People are advised against taking Diocid if they have certain conditions or are taking specific other medicines. This is because official documents explicitly contraindicate the medicine due to the risk of serious allergic reactions or dangerous drug-drug interactions, such as with certain antiretroviral agents.


Q: Is Diocid used for treating pain?

A: Official regulatory documents state that Diocid is indicated for treating conditions caused by excessive stomach acid, such as ulcers and gastroesophageal reflux disease (GERD). It is not indicated for the general treatment of pain.


Q: How quickly does Diocid start to work after taking it?

A: Regulatory information on the medicine’s activity indicates that the acid-reducing effect begins relatively quickly. The antisecretory effect typically starts within one hour after administration, with the maximum effect usually reached within two hours.


Q: What is the expected length of time Diocid stays in your system?

A: While the medicine itself is quickly cleared from the bloodstream, its functional effect on acid production lasts much longer. The official product information indicates the antisecretory activity in the stomach can persist for up to 72 hours.


Q: What happens if I miss a scheduled dose of Diocid?

A: Patient information advises that a missed dose may be taken as soon as it is remembered. If it is almost time for the next dose, the instructions state that the patient may skip the missed dose and resume the usual schedule.


Q: Does the official product information for Diocid mention weight gain as a common effect?

A: Weight increase has been reported in postmarketing experience. However, official warnings note that unexplained weight loss is a serious symptom that warrants medical attention.


Q: Is it true that Diocid has to be taken with a full glass of water?

A: The product labeling describes the capsule's administration as being swallowed whole with water. If the dosage form must be opened to ease swallowing, the contents are typically mixed with only a small amount of liquid or a soft food like applesauce.


Q: Is Diocid considered a controlled substance in the US or other countries?

A: Regulatory scheduling documents confirm that Diocid (Omeprazole) is not listed with a DEA Schedule. This means it is not classified as a controlled substance in the United States.


Q: Does taking Diocid affect the results of common blood tests?

A: Yes, official safety information indicates that the medicine can affect the results of certain laboratory tests. Specifically, it can increase levels of a substance called Chromogranin A (CgA), which may lead to false positive results when checking for neuroendocrine tumors.


Q: Is Diocid known to interact with aspirin or other over-the-counter painkillers?

A: The official interactions section primarily details interactions with prescription medicines. These include reducing the effectiveness of the antiplatelet medicine clopidogrel and interacting with some blood thinners like warfarin.


Q: What should a patient know about stopping Diocid after long-term use?

A: Studies show that the stomach's acid-secretion activity returns gradually after treatment is discontinued. This return to normal function typically occurs over a period of three to five days.


Q: Can Diocid cause problems with vision or eye health?

A: Adverse reaction reports mention problems related to vision. Blurred vision is listed as an adverse reaction, and irreversible visual impairment has been reported in rare cases following postmarketing experience.


Q: Is there a Black Box Warning associated with Diocid?

A: Official labeling confirms that there is no Black Box Warning associated with this medicine. A Black Box Warning is the strongest safety warning placed by the FDA on regulated products.


Q: Can Diocid interact with herbal remedies like St. John's Wort?

A: Regulatory documents caution against the concomitant use of the herbal remedy St. John's Wort. Co-administration may substantially decrease the medicine's concentration in the body.


Q: Are there specific warnings about sunlight exposure while using Diocid?

A: Official postmarketing reports include new or worsening symptoms of a condition called lupus, which may present as a skin rash. This rash often appears on the cheeks or arms and has been observed to worsen with exposure to sunlight.


Q: Does Diocid affect fertility in men or women?

A: Studies conducted in animals, which inform official regulatory documents, do not indicate effects with respect to fertility from using the medicine.


Q: Does taking antacids at the same time affect how Diocid works?

A: The official dosage and administration instructions confirm that antacids may be used concurrently with this medicine.

How should Diocid be stored and disposed of?

How to Store and Dispose of Diocid: Official Requirements

The storage of Diocid (Omeprazole) must strictly follow official regulatory guidelines to preserve its integrity.

Storage Conditions

Requirement Official Statement
Temperature Store at Controlled Room Temperature (typically 20 C to 25 C), avoiding temperatures above the specified limit (e.g., 30 C).
Protection Protect from moisture and light. Keep the medication in the original container and ensure the bottle is tightly closed to prevent moisture exposure.
Safety Keep out of the sight and reach of children and pets at all times.

Disposal Instructions

Disposal of unused or expired product must be in accordance with local regulatory requirements. Unless specifically instructed otherwise on the label, do not flush the product down the toilet or pour it down a drain. Use community drug take-back programs or dispose of the medicine safely in household trash by mixing it with an undesirable substance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diocid found in:

A-Z Index: